Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Spinal cord injury
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
MouseSpinal cord injuryContusionCD1 background: wild-type, EphB3 knockout, PLP-GFP wild-type and PLP-GFP-EphB3 knockout miceFemalen = ephrinB3 infusion n=6 versus vehicle n=14; PLP-GFP wild-typ…Intrathecal infusion into the injury epicentre via micro-osmotic pump (Alzet model 1007D) with Brain Infusion kit cannula100 micrograms/ml in the pump reservoir, delivered at 50 ng…Pump implanted at the time of surgery, immediately after laminectomy and contus…
Model: Contusive spinal cord injury: laminectomy at thoracic level 9 with Infinite Horizon impactor at 50 kDynes
Intrathecal ephrinB3 infusion increased surviving PLP-GFP oligodendrocytes at 7 days post injury (5870 plus or minus 742) versus vehicle (3547 plus or minus 510, P<0.05), but improved hindlimb locomotion was not observed. EphB3 knockout mice showed preserved oligodendrocyte numbers and myelin basic…
Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.9. Machine-extracted fields require source verification.